Supporting this, in a phase 2a trial in people with MASLD, the dual GLP-1/GCG agonist efinopegdutide (10 mg) reduced liver fat by 72.7%, compared to 42.3% with semaglutide (1 mg) despite similar WLindicating potential weight-independent effects of GCG on hepatic steatosis [40]
Its ideal for individuals with a BMI of 30 or higher (or 27+ with weight-related conditions) and offers significant, sustainable results when combined with a healthy lifestyle.By using QuickMD, you can start your weight loss journey without the hassle of in-person doctor visits or the stress of navigating insurance complications
Peer review Peer review information Nature Metabolism thanks Hamlet Gasoyan, Jason Halford and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Long-Term Safety Its uncertain if retatrutide is safe in the long term since its still being researched
We encourage you to explore our full collection of peptides and see the difference that an unwavering focus on quality makes
Tirzepatide works by slowing down how quickly food moves through your stomach and intestines